UCB 106607Alternative Names: UCB-106607
Latest Information Update: 21 Mar 2007
At a glance
- Originator UCB
- Class Antidepressants
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 11 Oct 2006 Phase-I clinical trials in Depression in Belgium (unspecified route)